4. Hermann J, Demel U, Stünzner D, Daghofer E, Tilz G, Graninger W. 2005; Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall. Ann Rheum Dis. 64:641–3. DOI:
10.1136/ard.2004.024877. PMID:
15485998. PMCID:
PMC1755429.
Article
7. Meyer O, Kahn MF, Grossin M, Ribard P, Belmatoug N, Morinet F, et al. 1991; Parvovirus B19 infection can induce histiocytic necrotizing lymphadenitis (Kikuchi's disease) associated with systemic lupus erythematosus. Lupus. 1:37–41. DOI:
10.1177/096120339100100107. PMID:
1845362.
Article
8. Watanabe Y, Inoue Y, Takatani T, Arai H, Yasuda T. 2009; Self-limited lupus-like presentation of human parvovirus B19 infection in a 1-year-old girl. Pediatr Int. 51:411–2. DOI:
10.1111/j.1442-200X.2009.02829.x. PMID:
19500282.
Article
10. Severin MC, Levy Y, Shoenfeld Y. 2003; Systemic lupus erythematosus and parvovirus B-19: casual coincidence or causative culprit? Clin Rev Allergy Immunol. 25:41–8. DOI:
10.1385/CRIAI:25:1:41. PMID:
12794260.
Article
12. Munakata Y, Saito-Ito T, Kumura-Ishii K, Huang J, Kodera T, Ishii T, et al. 2005; Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood. 106:3449–56. DOI:
10.1182/blood-2005-02-0536. PMID:
16076874.
Article
13. Dorsch S, Liebisch G, Kaufmann B, von Landenberg P, Hoffmann JH, Drobnik W, et al. 2002; The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol. 76:2014–8. DOI:
10.1128/JVI.76.4.2014-2018.2002. PMID:
11799199. PMCID:
PMC135890.
Article
14. Chun LH, Kim TY. 2001; Human parvovirus B19 and rheumatoid arthritis in Korea. J Korean Rheum Assoc. 8:14–9.
15. Yoon HJ, Lee SS, Juhng H. 2005; A case of parvovirus B19 related arthropathy associated with antinuclear antibody, anti-Ro/SSA and anti-La/SSB. J Korean Rheum Assoc. 12:52–6.